• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT Back to Search Results
Lot Number 0031052709
Device Problems Break (1069); Difficult to Advance (2920)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/04/2023
Event Type  malfunction  
Event Description
It was reported that shaft break occurred.The 95% stenosed target lesion was located in the moderately tortuous and severely, diffusely calcified right coronary artery (rca).The ostium of the rca was aneurysmal in nature and had an anterio-lateral take-off which made it difficult to find a guide catheter to suitably engage the rca and provide adequate support for the procedure.A 6fr al2 guide catheter was selected which provided sub-optimal support.A rotablation was attempted, however, the guide did not provide adequate support so no rotational atherectomy was performed.A 6fr guidezilla ii was inserted over a non-boston scientific (bsc) guidewire and a 2.75 x 20mm synergy xd was successfully deployed in the mid-rca.A 3.00 x 20mm synergy xd was then advanced for treatment of the proximal rca, however; significant resistance was felt while advancing the synergy xd through the distal third of the distal lumen segment of the guidezilla ii.It was noted that this was caused by the acute angle of the guidezilla as it exited the al2 guide catheter and turned into the ostium of the rca.Advancement of the device required significant force which bent the hypotube outside of the hemostasis valve.The physician attempted to straighten the hypotube, however, it snapped at the point of the kink approximately 110cm from the stent balloon towards the hub of the device outside of the patient's body.The device was removed intact from the patient.The angle of the guidezilla ii and guide catheter was corrected, and the procedure was completed with another of the same device.There was good angiographic result and no patient complications were reported.
 
Manufacturer Narrative
E1.Initial reporter phone: (b)(6).
 
Manufacturer Narrative
E1.Initial reporter phone: (b)(6).Device evaluated by mfr: synergy xd mr ous 3.00 x 20mm stent delivery system (sds) was returned to the complaint investigation site (cis).A visual, tactile and microscopic examination identified a break was noted at 22cm distal to the distal end of the strain relief along the length of the hypotube shaft.No issues identified with the outer / mid-shaft sections or the inner lumen of the device.A microscopic examination shows there was no sign of damage, stretching or lifting of the stent struts.Balloon cones were reviewed, and no issues were noted.Balloon wings were tightly wrapped and evenly folded and were not subjected to positive pressure.No signs of movement, stent was set between the proximal and distal markerbands.Bumper tip showed no signs of distal tip damage.A device-to-device interaction test shows device could be loaded and tracked over a 0.014" guidewire without issue.
 
Event Description
It was reported that shaft break occurred.The 95% stenosed target lesion was located in the moderately tortuous and severely, diffusely calcified right coronary artery (rca).The ostium of the rca was aneurysmal in nature and had an anterio-lateral take-off which made it difficult to find a guide catheter to suitably engage the rca and provide adequate support for the procedure.A 6fr al2 guide catheter was selected which provided sub-optimal support.A rotablation was attempted, however, the guide did not provide adequate support so no rotational atherectomy was performed.A 6fr guidezilla ii was inserted over a non-boston scientific (bsc) guidewire and a 2.75 x 20mm synergy xd was successfully deployed in the mid-rca.A 3.00 x 20mm synergy xd was then advanced for treatment of the proximal rca, however; significant resistance was felt while advancing the synergy xd through the distal third of the distal lumen segment of the guidezilla ii.It was noted that this was caused by the acute angle of the guidezilla as it exited the al2 guide catheter and turned into the ostium of the rca.Advancement of the device required significant force which bent the hypotube outside of the hemostasis valve.The physician attempted to straighten the hypotube, however, it snapped at the point of the kink approximately 110cm from the stent balloon towards the hub of the device outside of the patient's body.The device was removed intact from the patient.The angle of the guidezilla ii and guide catheter was corrected, and the procedure was completed with another of the same device.There was good angiographic result and no patient complications were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY XD
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key18378238
MDR Text Key331378805
Report Number2124215-2023-69979
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeAS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/09/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Lot Number0031052709
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/04/2023
Initial Date FDA Received12/21/2023
Supplement Dates Manufacturer Received01/17/2024
Supplement Dates FDA Received02/09/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/01/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-